TFDA Thailand Medical Device Registration

Medical devices sold in Thailand are regulated by the Medical Device Control Division (MDCD) within the Thai Food and Drug Administration (Thai FDA). Current medical device regulations in Thailand include:

• Medical Device Act B.E. 2551 (2008) and

• Medical Device Act (No. 2) B.E. 2562 (2019), which amended the earlier Act.

Any company that manufactures or imports medical devices for sale in Thailand must first obtain the appropriate license to produce or import their devices. Foreign manufacturers must also appoint a local authorized representative (LAR) to hold the license and act as the importer.

Thai FDA medical device regulatory pathways

Thailand classifies devices and IVDs into four risk-based classes: Class 1, 2, 3, and 4. The classification determines the regulatory route: Listing, Notification, or Licensing.

Listing Route (Class 1 devices and IVDs)

• Process: Manufacturers of low-risk devices submit a Listing application via their license holder. Class 1 devices on the Thai FDA Positive List may qualify for automatic approval.

• Requirements: Documentation includes product labeling, Instructions for Use (IFU), device description, Declaration of Conformity, and Letter of Authorization.

• Timeline: Positive List devices may be approved within days. Others may take several weeks.

• Renewal: Licenses must be renewed every five years.

Notification Route (Class 2 and 3 devices and IVDs)

• Process: Devices of moderate risk require submission of a Common Submission Dossier Template (CSDT) to the Thai FDA.

• Requirements: The dossier includes device description, risk analysis, ISO 13485 certificate, clinical or performance data, and Letter of Authorization.

• Timeline: Standard review may take several months. Abridged or Reliance Routes are available to reduce timelines if eligibility criteria are met.

• Renewal: Five-year renewal cycle.

Licensing Route (Class 4 devices and IVDs)

• Process: High-risk devices undergo full Thai FDA review with a complete CSDT submission.

• Requirements: Full technical dossier including manufacturing details, quality system certification (e.g., ISO 13485), clinical data, and authorization letters. Devices approved by recognized agencies may qualify for abridged documentation.

• Timeline: Full reviews typically take several months. Abridged or Reliance Route (e.g., Singapore HSA-approved devices) may bypass specialist review and reduce approval time by 1–3 months.

• Renewal: Renewed every five years.

Other Thai FDA registration requirements

• Local authorized representative: All foreign manufacturers must appoint a Thailand-based representative with an Establishment License to hold the registration and act as the importer.

• Translation: IFUs and labeling must be in Thai for home-use devices. For professional-use devices, English is acceptable.

• Quality system evidence: Class 2–4 products must provide an ISO 13485 Certificate or Thai GMP certificate. Class 1 must adhere to Thai GMP guidelines but are exempt from certification.

• Post-market obligations: License holders must conduct vigilance reporting through the Thai FDA for incidents occurring domestically or abroad. PMS reports are due annually.

• Labels and UDI: Apply the current labeling notification effective 20 June 2026, including its product, user and transition provisions. Assess UDI implementation separately against current Thai FDA instructions; do not treat a historical labeling draft as the binding UDI rollout timetable.

What documentation is required to register a medical device or IVD in Thailand?

Documentation depends on the classification:

For Listing (Class 1 devices):

• Product labeling

• IFU in Thai (for home use)

• Device description and materials

• Declaration of Conformity

• Letter of Authorization

For Notification or Licensing (Class 2–4 devices):

• Full Common Submission Dossier Template (CSDT)

• ISO 13485 or Thai GMP certificate

• Clinical or performance evidence

• Letter of Authorization

Does my device qualify for the Abridged or Reliance Route?

Devices may qualify if they meet the following criteria:

• Abridged Route: Approval by US FDA, EU Notified Body, TGA, MHLW, Health Canada, or WHO Prequalification for at least one year. Some technical documents may be waived.

• Reliance Route: Approval by Singapore’s HSA with identical submission dossier and written consent to share documents. Specialist review is waived, saving up to three months.

What is a Thai local authorized representative and why do you need one?

The local authorized representative (LAR) is a legal entity based in Thailand that acts on behalf of a medical device manufacturer not based in Thailand. The LAR is responsible for submitting the application, ensuring regulatory compliance, managing post-market obligations, holding the registration, and acting as the importer, which includes obtaining permits for each shipment (LPIs). The LAR must possess an Establishment License and serves as the official point of contact with the Thai FDA. Only entities based in Thailand can perform this role.

Current pathway and launch dependencies

The official commercial-supply process separates establishment readiness, classification and device registration. Foreign authorization can support a qualified evaluation route but does not set the Thai class. The current labeling instrument has an effective date of June 20, 2026; do not keep presenting it as an unfinalized March 2025 draft. Check the UDI program page separately for current implementation status.

Use the official Thai FDA instructions for the precise category, forms, fees and supporting records. Maintain a product-level plan covering evidence gaps, local permissions, filing, authority questions and release. Government charges, certification/audit, translations and service fees are separate; avoid undated currency conversions or a guaranteed approval date. Connect the plan to the market's classification, labeling and postmarket guides below.